Zilico Ltd featured in 100 Stories of Growth 2018

Wednesday 13th June 2018

Enterprise Investment Scheme investment has helped Zilico reach its commercial goals, a journey which has been hindered by prolonged product development and the global financial crisis.

Read the full story here: Zilico - 100 Stories of Growth

Sameer Kothari, Zilico's CEO offers his response to the article.

On further reflection, the Zilico story is about the vision the founders had from day one on the benefits of the technology and how, when applied to disease pathways it would generate better outcomes for patients, clinicians and healthcare systems. We had great data from the start with the first study published in the  Lancet which added to our knowledge of how disease impacts cellular changes and tissue structure.  ZedScan, our cervical cancer diagnostic is providing clinicians with additional information and helping them better manage their patients. Real-world data from the several NHS centres that have adopted ZedScan, shows the device is helping with better outcomes – detecting more disease as well as providing reassurance to return women to routine surveillance.